US 8546091
AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy
granted A61PA61P35/00A61P35/04
Quick answer
US patent 8546091 (AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P35/00, A61P35/04